New Zealand markets closed

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.37+0.09 (+1.70%)
At close: 04:00PM EDT
5.17 -0.20 (-3.72%)
After hours: 07:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.08M
Enterprise value 949.42k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.37
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.21

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-96.45%
S&P500 52-week change 326.27%
52-week high 3180.25
52-week low 34.44
50-day moving average 37.12
200-day moving average 324.03

Share statistics

Avg vol (3-month) 3410.15k
Avg vol (10-day) 31.01M
Shares outstanding 5759.49k
Implied shares outstanding 6759.49k
Float 8749.61k
% held by insiders 10.83%
% held by institutions 12.65%
Shares short (30 Apr 2024) 415.58k
Short ratio (30 Apr 2024) 40.04
Short % of float (30 Apr 2024) 42.06%
Short % of shares outstanding (30 Apr 2024) 42.05%
Shares short (prior month 28 Mar 2024) 458.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 326 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-12.82%
Return on equity (ttm)-177.53%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -14.41M
Net income avi to common (ttm)-106.25M
Diluted EPS (ttm)-1,089.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.14M
Total cash per share (mrq)4.13
Total debt (mrq)8.66k
Total debt/equity (mrq)0.08%
Current ratio (mrq)0.33
Book value per share (mrq)27.33

Cash flow statement

Operating cash flow (ttm)-8.72M
Levered free cash flow (ttm)-5.46M